$1.14
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. The company is headquartered in Guilford, Connecticut and currently employs 102 full-time employees. The company went IPO on 2021-01-27. The firm is engaged in providing patient care globally through artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. Its Swoop Portable MR Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional magnetic resonance imaging (MRI) scanners. Its Swoop system is designed to transform brain MR for the patient, the clinician and the provider, enabling a highly differentiated experience for patients, timely imaging for clinicians, and favorable economics for hospital administrators. The Swoop system is a portable ULF MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. The Swoop system is FDA-cleared for brain imaging of patients of all ages. The Swoop system is commercially available in a select number of international markets.
Country

US

CEO

Ms. Maria Sainz

IPO date

2021

Employees

102

ISIN

US44916K1060

Key stats

Open

$1.12

Volume

1.13M

Market cap

$110.69M

Prev. close

$1.12

Impl / hst vl

-

Open interest

$0.00

$1.12

Day’s Range

$1.14

$0.95

52W Range

$1.94

Valuation

55
Valuation score
Fairly Valued
P/E
-
P/S
7.22
P/B
3.22
Current ratio
5.52
Debt / Equity
-0.80
ROE
-101.28%
Gross margin
50.70%
Income growth
45.86%
FCF growth
75.52

Analysts estimates

Consensus rating
Buy

The average rating from top 5 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$2.21
The top 5 analysts forecasts that 12-month price may increase by 93.86%, with a low of $2.02 and a high of $2.63
$2.02
Low
$2.21
Avg
$2.63
High
Current price

Earnings

Q1 ‘26 revenue
$3.90M
Q1 ‘26 net income
-$8.62M
Revenue
Net income
Previous EPS
-$0.08
Estimate EPS
-$0.09
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply